• I-BET-762: BET Inhibitor Workflows for Ferroptosis & Inflamm

  2026-04-22

  I-BET-762 streamlines workflows for dissecting BET-driven transcriptional regulation and ferroptosis sensitivity in preclinical models. Its nanomolar selectivity and synergy with ferroptosis inducers unlock new options for cancer and inflammation research, with actionable troubleshooting insights and protocol guidance.

• Temozolomide: Applied Workflows for DNA Repair and Glioma Re

  2026-04-22

  Temozolomide stands out as a small-molecule alkylating agent enabling rigorous, reproducible DNA repair and chemotherapy resistance studies in glioma and cancer models. This article unpacks optimized protocols, troubleshooting strategies, and the latest experimental insights, including how ATRX status transforms assay design and therapeutic hypotheses.

• 0.4% Trypan Blue Solution: Technical Guidance for Cell Viabi

  2026-04-21

  0.4% Trypan Blue Solution is a membrane-impermeable azo dye for selective staining of dead or damaged cells, enabling rapid and reliable cell viability measurement in cell culture and cytotoxicity assays. It is not intended for diagnostic or clinical use, and its application is limited to research protocols requiring live/dead cell discrimination. Use is recommended where precise assessment of cellular viability is essential, but it should not substitute for mechanistic apoptosis or necrosis assays.

• Bordetella BteA Effector Drives IL-1Ra Expression via Akt/mT

  2026-04-21

  This study uncovers how the Bordetella T3SS effector BteA manipulates host epithelial and eosinophil signaling to upregulate IL-1Ra, promoting bacterial persistence. By elucidating the underlying Akt/mTOR pathway activation and its independence from canonical IL-1 signaling, the findings reveal new therapeutic entry points for chronic respiratory infections.

• Geneticin, G-418 Sulfate: Precision Selection and Antiviral

  2026-04-20

  Explore the dual utility of G418 Sulfate (Geneticin) as both a gold-standard genetic selection antibiotic and a mechanistic probe in antiviral research. This article uniquely integrates ribosomal inhibition, Dengue virus suppression, and translational insights from ferroptosis studies to inform advanced assay design.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): Mechanism

  2026-04-20

  Diuron, a high-purity photosynthesis inhibitor, is pivotal in plant biology and toxicology research. Recent studies reveal its nephrotoxic mechanism via the JAK2/STAT1 pathway. This article details Diuron’s action, applications, and research benchmarks for advanced laboratory workflows.

• Imipenem in Translational Research: Mechanisms & Strategic F

  2026-04-19

  This article examines Imipenem—a semisynthetic thienamycin antibiotic from APExBIO—as a paradigm for mechanistic antibacterial research and translational immune modulation. We move beyond product basics to synthesize molecular mechanistic insights, validation in sepsis and immune response models, and strategic guidance for translational scientists confronting resistance. By embedding numeric claims with rigorous citations and highlighting competitive agents like ceftolozane/tazobactam, we define new directions for resistance modeling and translational workflows.

• DMXAA (Vadimezan): Protocols and Innovations in Tumor Vascul

  2026-04-18

  DMXAA (Vadimezan) stands out as a next-generation vascular disrupting agent, uniquely combining DT-diaphorase inhibition and anti-angiogenic activity for advanced cancer biology research. This article delivers detailed experimental workflows, troubleshooting strategies, and actionable insights from the latest endothelial STING-JAK1 findings—empowering researchers to unlock new dimensions in tumor microenvironment modulation.

• Deep Learning Enables Scalable Cardiotoxicity Screening in i

  2026-04-17

  This study demonstrates that deep learning applied to high-content imaging of human iPSC-derived cardiomyocytes can rapidly and sensitively detect drug-induced cardiotoxicity. The approach identifies both known and novel cardiotoxic compounds, offering a scalable, phenotypic screening method to de-risk early drug discovery.

• Viral-Induced RIPK3 Degradation Modulates Necroptosis and In

  2026-04-16

  This study identifies a class of viral proteins from orthopoxviruses that induce the degradation of the necroptosis adaptor RIPK3 via hijacking the host SCF ubiquitin ligase machinery. The work reveals a new viral immune evasion strategy with implications for understanding virus-host interactions, inflammation, and the potential for targeted research using neddylation pathway inhibitors.

• Cefotaxime: Third-Generation Cephalosporin in Resistance Mod

  2026-04-15

  Cefotaxime’s resistance to beta-lactamases and broad-spectrum efficacy make it a cornerstone for rigorous antimicrobial resistance and infection model research. This article unpacks stepwise workflows, protocol parameters, and expert troubleshooting for leveraging APExBIO’s high-purity Cefotaxime in advanced experimental settings.

• X-Gal in Blue-White Colony Screening: Protocols & Innovation

  2026-04-14

  X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) is indispensable for blue-white colony screening, enabling rapid, visual identification of recombinant clones in molecular cloning. Leveraging APExBIO’s high-purity X-Gal ensures superior assay reliability, reproducibility, and integration with advanced molecular workflows.

• PZP Hepatokine Activates Brown Fat Thermogenesis via GRP78 B

  2026-04-13

  This study identifies pregnancy zone protein (PZP) as a hepatokine induced by intermittent fasting, which activates brown adipose tissue (BAT) thermogenesis via GRP78 engagement and p38 MAPK-ATF2 signaling. The findings clarify a liver-to-adipose axis in diet-induced energy expenditure, offering a novel therapeutic target for obesity and metabolic disorders.

• Cisapride (R 51619) in Cardiac Electrophysiology Research

  2026-04-12

  Cisapride (R 51619) empowers cardiac electrophysiology and cardiotoxicity workflows, especially with iPSC-derived cardiomyocytes and deep learning-enabled phenotypic screens. APExBIO’s validated, high-purity formulation enhances reproducibility and reliability in hERG channel and 5-HT4 signaling investigations.

• Guanabenz Acetate: Precision α2-Adrenergic Receptor Agonist

  2026-04-12

  Guanabenz Acetate enables selective α2-adrenergic receptor activation, empowering advanced GPCR signaling and innate immune research with high reproducibility. Learn how to optimize protocols and troubleshoot common pitfalls using APExBIO’s trusted, high-purity reagent.

16413 records 1/1095 page Next 12345 下5页 Last page